2024-01-012024-12-312024-12-31false10846216Derma4U Ltd2025-09-30falseiso4217:GBPxbrli:pure108462162023-12-31108462162024-12-31108462162024-01-012024-12-31108462162022-12-31108462162023-12-31108462162023-01-012023-12-3110846216bus:SmallEntities2024-01-012024-12-3110846216bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3110846216bus:FullAccounts2024-01-012024-12-3110846216bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110846216core:WithinOneYear2024-12-3110846216core:AfterOneYear2024-12-3110846216core:WithinOneYear2023-12-3110846216core:AfterOneYear2023-12-3110846216core:ShareCapital2024-12-3110846216core:SharePremium2024-12-3110846216core:RevaluationReserve2024-12-3110846216core:OtherReservesSubtotal2024-12-3110846216core:RetainedEarningsAccumulatedLosses2024-12-3110846216core:ShareCapital2023-12-3110846216core:SharePremium2023-12-3110846216core:RevaluationReserve2023-12-3110846216core:OtherReservesSubtotal2023-12-3110846216core:RetainedEarningsAccumulatedLosses2023-12-3110846216core:LandBuildings2024-12-3110846216core:PlantMachinery2024-12-3110846216core:Vehicles2024-12-3110846216core:FurnitureFittings2024-12-3110846216core:OfficeEquipment2024-12-3110846216core:NetGoodwill2024-12-3110846216core:IntangibleAssetsOtherThanGoodwill2024-12-3110846216core:ListedExchangeTraded2024-12-3110846216core:UnlistedNon-exchangeTraded2024-12-3110846216core:LandBuildings2023-12-3110846216core:PlantMachinery2023-12-3110846216core:Vehicles2023-12-3110846216core:FurnitureFittings2023-12-3110846216core:OfficeEquipment2023-12-3110846216core:NetGoodwill2023-12-3110846216core:IntangibleAssetsOtherThanGoodwill2023-12-3110846216core:ListedExchangeTraded2023-12-3110846216core:UnlistedNon-exchangeTraded2023-12-3110846216core:LandBuildings2024-01-012024-12-3110846216core:PlantMachinery2024-01-012024-12-3110846216core:Vehicles2024-01-012024-12-3110846216core:FurnitureFittings2024-01-012024-12-3110846216core:OfficeEquipment2024-01-012024-12-3110846216core:NetGoodwill2024-01-012024-12-3110846216core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110846216core:ListedExchangeTraded2024-01-012024-12-3110846216core:UnlistedNon-exchangeTraded2024-01-012024-12-3110846216core:MoreThanFiveYears2024-01-012024-12-3110846216core:Non-currentFinancialInstruments2024-12-3110846216core:Non-currentFinancialInstruments2023-12-3110846216dpl:CostSales2024-01-012024-12-3110846216dpl:DistributionCosts2024-01-012024-12-3110846216core:LandBuildings2024-01-012024-12-3110846216core:PlantMachinery2024-01-012024-12-3110846216core:Vehicles2024-01-012024-12-3110846216core:FurnitureFittings2024-01-012024-12-3110846216core:OfficeEquipment2024-01-012024-12-3110846216dpl:AdministrativeExpenses2024-01-012024-12-3110846216core:NetGoodwill2024-01-012024-12-3110846216core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110846216dpl:GroupUndertakings2024-01-012024-12-3110846216dpl:ParticipatingInterests2024-01-012024-12-3110846216dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3110846216core:ListedExchangeTraded2024-01-012024-12-3110846216dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3110846216core:UnlistedNon-exchangeTraded2024-01-012024-12-3110846216dpl:CostSales2023-01-012023-12-3110846216dpl:DistributionCosts2023-01-012023-12-3110846216core:LandBuildings2023-01-012023-12-3110846216core:PlantMachinery2023-01-012023-12-3110846216core:Vehicles2023-01-012023-12-3110846216core:FurnitureFittings2023-01-012023-12-3110846216core:OfficeEquipment2023-01-012023-12-3110846216dpl:AdministrativeExpenses2023-01-012023-12-3110846216core:NetGoodwill2023-01-012023-12-3110846216core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3110846216dpl:GroupUndertakings2023-01-012023-12-3110846216dpl:ParticipatingInterests2023-01-012023-12-3110846216dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3110846216core:ListedExchangeTraded2023-01-012023-12-3110846216dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3110846216core:UnlistedNon-exchangeTraded2023-01-012023-12-3110846216core:NetGoodwill2024-12-3110846216core:IntangibleAssetsOtherThanGoodwill2024-12-3110846216core:LandBuildings2024-12-3110846216core:PlantMachinery2024-12-3110846216core:Vehicles2024-12-3110846216core:FurnitureFittings2024-12-3110846216core:OfficeEquipment2024-12-3110846216core:AfterOneYear2024-12-3110846216core:WithinOneYear2024-12-3110846216core:ListedExchangeTraded2024-12-3110846216core:UnlistedNon-exchangeTraded2024-12-3110846216core:ShareCapital2024-12-3110846216core:SharePremium2024-12-3110846216core:RevaluationReserve2024-12-3110846216core:OtherReservesSubtotal2024-12-3110846216core:RetainedEarningsAccumulatedLosses2024-12-3110846216core:NetGoodwill2023-12-3110846216core:IntangibleAssetsOtherThanGoodwill2023-12-3110846216core:LandBuildings2023-12-3110846216core:PlantMachinery2023-12-3110846216core:Vehicles2023-12-3110846216core:FurnitureFittings2023-12-3110846216core:OfficeEquipment2023-12-3110846216core:AfterOneYear2023-12-3110846216core:WithinOneYear2023-12-3110846216core:ListedExchangeTraded2023-12-3110846216core:UnlistedNon-exchangeTraded2023-12-3110846216core:ShareCapital2023-12-3110846216core:SharePremium2023-12-3110846216core:RevaluationReserve2023-12-3110846216core:OtherReservesSubtotal2023-12-3110846216core:RetainedEarningsAccumulatedLosses2023-12-3110846216core:NetGoodwill2022-12-3110846216core:IntangibleAssetsOtherThanGoodwill2022-12-3110846216core:LandBuildings2022-12-3110846216core:PlantMachinery2022-12-3110846216core:Vehicles2022-12-3110846216core:FurnitureFittings2022-12-3110846216core:OfficeEquipment2022-12-3110846216core:AfterOneYear2022-12-3110846216core:WithinOneYear2022-12-3110846216core:ListedExchangeTraded2022-12-3110846216core:UnlistedNon-exchangeTraded2022-12-3110846216core:ShareCapital2022-12-3110846216core:SharePremium2022-12-3110846216core:RevaluationReserve2022-12-3110846216core:OtherReservesSubtotal2022-12-3110846216core:RetainedEarningsAccumulatedLosses2022-12-3110846216core:AfterOneYear2024-01-012024-12-3110846216core:WithinOneYear2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110846216core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3110846216core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3110846216core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3110846216core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3110846216core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3110846216bus:Director12024-01-012024-12-31108462161bus:Director12023-12-31108462161bus:Director12024-01-012024-12-31108462161bus:Director12024-12-31108462162023-12-31108462162024-01-012024-12-31108462162024-12-31

Derma4U Ltd

Registered Number
10846216
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

Derma4U Ltd
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

Lorna M Dunn

Registered Address

20-22 Wenlock Road
London
N1 7GU

Registered Number

10846216 (England and Wales)
Derma4U Ltd
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets33,2172,292
3,2172,292
Current assets
Debtors498,153164,621
Cash at bank and on hand224,47124,138
322,624188,759
Creditors amounts falling due within one year5(252,571)(122,362)
Net current assets (liabilities)70,05366,397
Total assets less current liabilities73,27068,689
Creditors amounts falling due after one year6(23,459)(27,887)
Net assets49,81140,802
Capital and reserves
Called up share capital11
Profit and loss account49,81040,801
Shareholders' funds49,81140,802
The financial statements were approved and authorised for issue by the Director on 30 September 2025, and are signed on its behalf by:
Lorna M Dunn
Director
Registered Company No. 10846216
Derma4U Ltd
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
Government grants or assistance
Government revenue grants are recognised in the financial statements in the period in which they are received. Any related expenditure is not offset but recognised separately within the same financial period as the income is received.
2.Average number of employees

20242023
Average number of employees during the year41
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 245,2785,278
Additions1,9991,999
At 31 December 247,2777,277
Depreciation and impairment
At 01 January 242,9862,986
Charge for year1,0741,074
At 31 December 244,0604,060
Net book value
At 31 December 243,2173,217
At 31 December 232,2922,292
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables18,16092,493
Amounts owed by associates and joint ventures / participating interests73,53571,726
Other debtors6,458402
Total98,153164,621
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables70,53737,016
Bank borrowings and overdrafts4,4285,348
Taxation and social security71,49676,843
Other creditors100,271155
Accrued liabilities and deferred income5,8393,000
Total252,571122,362
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. Included in Bank Borrowings due within one year is a Bounce Back Loan which is denominated in GBP with a nominal interest rate of 2.5%, with the final instalment being due in May 2026. The total due within one year at the period end was £4,428 (2023 - £4428). This loan is guaranteed by the Government.
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts23,45927,887
Total23,45927,887
Included in Bank Borrowings due after one year is a Bounce Back Loan which is denominated in GBP with a nominal interest rate of 2.5%, with the final installment being due in May 2026. The total due after one year at the period end was £23,459 (2023 - £27,887). This loan is guaranteed by the Government.
7.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Lorna M Dunn44,45051,80950,00046,259
44,45051,80950,00046,259
These monies had been advanced to enable the Director to carry out her duties and had been made on an unsecured, interest free basis. This loan was repaid within nine months of the year end.
8.Related party transactions
During the period, loans were made to Companies under common control amounting to £27,276 (2023: £27,276). These loans having been advanced on an unsecured, interest free basis, being repayable upon demand.